REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
11/01/2025
Back to search
Official data from USPTO
ACE CANCERPLUS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
ACE CANCERPLUS
ST13
US500000086749917Class
42, 44
Filing
86749917
Registration
5074734
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
27
Latest update
02/27/2026
Trademark type
Word
Nice classes
42, 44
Filing date
09/08/2015
Registration date
11/01/2016
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/09/2023
Last transaction
02/27/2026
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
2015-06-00
First use in commerce
2015-06-00
Drawing code
4
Owner type
03
Owner location
Menlo Park, CA, US
Examiner
CHADAB, SETH WILLIG
Law office
L40
Current location
TMEG LAW OFFICE 104
Holders and representatives
Holders
Personalis, Inc.
Representatives
Laura C. Miller Kilpatrick Townsend & Stockton LLP
Technical classification
Nice Classes
Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Providing genome sequencingdata analysis and interpretationassay development and preparingamplifyinglabelingdetectinganalyzing and sequencing nucleic acids and other biological moleculesresearch and design relating theretoall in the field of bioinformaticsgenomics and gene expression research and development
Class 44
Analysis of cellstissuesgene expressionsgene sequencesgenome annotationtranscriptome characterizationgenome mapping for medical diagnosis and treatment; Preparation of reports relating to gene expressionsgene and genome sequencesgenome interaction and annotationtranscriptome analysis and characterizationgenome mapping for medical diagnosis and treatment
Publications
History of USPTO decisions and trademark events.
27 publications found
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
05/09/2023
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
05/09/2023
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
05/09/2023
E815
TEAS SECTION 8 & 15 RECEIVED
10/28/2022
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
11/01/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
09/24/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
09/24/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
09/24/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
11/01/2016
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
09/28/2016
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
09/27/2016
SUPC
STATEMENT OF USE PROCESSING COMPLETE
09/17/2016
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
09/17/2016
IUAF
USE AMENDMENT FILED
08/24/2016
EISU
TEAS STATEMENT OF USE RECEIVED
08/24/2016
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
03/29/2016
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
03/03/2016
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
03/03/2016
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/02/2016
PUBO
PUBLISHED FOR OPPOSITION
02/02/2016
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/13/2016
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/03/2015
DOCK
ASSIGNED TO EXAMINER
11/20/2015
MPMK
NOTICE OF PSEUDO MARK E-MAILED
09/12/2015
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/11/2015
NWAP
NEW APPLICATION ENTERED
09/11/2015
Continuous trademark protection
Get notified about every new filing that threatens ACE CANCERPLUS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.